Follicular lymphoma

A Carbone, S Roulland, A Gloghini, A Younes… - Nature reviews Disease …, 2019 - nature.com
Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal
centre (GC) B cell differentiation. FL represents~ 5% of all haematological neoplasms and …

Follicular lymphoma: 2020 update on diagnosis and management

A Freedman, E Jacobsen - American journal of hematology, 2020 - Wiley Online Library
Disease overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is …

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

M Dreyling, M Ghielmini, S Rule, G Salles… - Annals of …, 2021 - annalsofoncology.org
Diagnosis should be based on a surgical specimen/excisional lymph node (LN) biopsy.
Core biopsies should only be carried out in patients without easily accessible LNs (eg …

[HTML][HTML] Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study

E Bachy, JF Seymour, P Feugier, F Offner… - Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
METHODS Patients (> 18 years of age) with previously untreated high–tumor-burden
follicular lymphoma were nonrandomly assigned to receive one of three …

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis …

V Poeschel, G Held, M Ziepert, M Witzens-Harig… - The Lancet, 2019 - thelancet.com
Background Six cycles of R-CHOP (rituximab plus cyclophosphamide, doxorubicin,
vincristine, and prednisone) are the standard treatment for aggressive B-cell non-Hodgkin …

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

CL Batlevi, F Sha, A Alperovich, A Ni, K Smith… - Blood cancer …, 2020 - nature.com
Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …

Follicular lymphoma: 2023 update on diagnosis and management

E Jacobsen - American Journal of Hematology, 2022 - Wiley Online Library
Abstract Disease Overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Response-adapted postinduction strategy in patients with advanced-stage follicular lymphoma: the FOLL12 study

S Luminari, M Manni, S Galimberti, A Versari… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE We compared 2 years of rituximab maintenance (RM) with a response-adapted
postinduction approach in patients with follicular lymphoma who responded to induction …

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

M Federico, MDC Barrigón, L Marcheselli… - The Lancet …, 2018 - thelancet.com
Background Histological transformation of follicular lymphoma to aggressive lymphoma is a
serious event with a substantial effect on patient outcome. The aim of the Aristotle study was …

An introduction to the clinical practice of theranostics in oncology

JH Turner - The British journal of radiology, 2018 - academic.oup.com
“Those who cannot remember the past are condemned to repeat it.” George Santayana
1905 “If men could learn from history, what lessons it might teach us! But passion and party …